Dose-ranging Trial to Evaluate Delgocitinib Cream 1, 3, 8, and 20 mg/g Compared to Delgocitinib Cream Vehicle Over an 8-week Treatment Period in Adult Subjects With Atopic Dermatitis.
Clinical trial NCT03725722 · COMPLETED
Trial details
- NCT number
- NCT03725722
- Sponsor
- LEO Pharma
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-28
- Primary completion
- 2020-05-19
- Enrollment
- 251
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.